Welcome to our dedicated page for Amn Healthcare SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking clinician supply swings or dissecting managed services contracts inside AMN Healthcare’s filings can feel like searching for vital signs in a crowded ER. Each Form 10-K details dozens of business lines—travel nurses, allied staffing, language services—while sudden 8-K announcements flag acquisitions that reshape margins overnight. Finding the numbers that explain seasonal demand or technology spend is the problem investors face.
Stock Titan’s AI delivers the solution. Our platform turns a 300-page annual report into a concise briefing—AMN Healthcare annual report 10-K simplified. Need to know whether executives bought shares after a big contract win? Receive AMN Healthcare Form 4 insider transactions real-time alerts. Want quick context for a surprise disclosure? See AMN Healthcare 8-K material events explained alongside expert commentary. We also answer the everyday questions people type into search bars: “understanding AMN Healthcare SEC documents with AI”, “AMN Healthcare quarterly earnings report 10-Q filing”, and “AMN Healthcare proxy statement executive compensation”. Our AI parses footnotes, flags new risk factors, and surfaces segment revenue so you can act faster.
Every filing type is covered and refreshed the moment it hits EDGAR—10-Q trends for travel nurse bill rates, 10-K disclosures on MSP penetration, 8-K updates on technology acquisitions, plus AMN Healthcare insider trading Form 4 transactions. Use our tools to:
- Monitor AMN Healthcare executive stock transactions Form 4
- Compare staffing demand quarter-over-quarter with our AMN Healthcare earnings report filing analysis
- Audit governance details through the latest proxy
Whitney M. Laughlin, Chief Legal Officer of AMN Healthcare Services, reported on Form 4 that 483 restricted stock units (RSUs) vested on September 15, 2025, converting into 483 shares of AMN common stock. Of those shares, 118 were sold or withheld at $18.25 per share to satisfy tax withholding, leaving the reporting person with 16,732 shares beneficially owned after the transactions. The RSUs were originally granted under the AMN Healthcare 2017 Equity Plan on September 15, 2023 and vest in three annual tranches; the units have no expiration date. The report is a routine insider equity vesting and tax-withholding transaction rather than a discretionary open-market purchase or sale.
FMR LLC and its chair & CEO Abigail P. Johnson have filed a Schedule 13G disclosing a 6.2 % passive stake in AMN Healthcare Services, Inc. (AMN) as of 30 Jun 2025. The position equals 2,391,522.85 common shares.
- Sole voting power: 2,388,349 shares
- Sole dispositive power: 2,391,522.85 shares
- Shared voting/dispositive power: 0 shares
The filing is made under Rule 13d-1(b) by a parent holding company/control person. An affiliated fund, Fidelity Small Cap Value Fund, holds 1,980,849 shares (5.2 %) within the aggregate amount. The signatory certifies the stake is held in the ordinary course of business without intent to influence control.
While no purchase history or cost basis is provided, FMR’s >5 % ownership signals continued institutional interest in AMN. No other material events, financial results, or strategic actions are disclosed.
FAQ
What is the current stock price of Amn Healthcare (AMN)?
What is the market cap of Amn Healthcare (AMN)?
